Karyopharm Therapeutics (KPTI) Selling, General & Administrative (2012 - 2026)

Karyopharm Therapeutics (KPTI) Selling, General & Administrative (2012 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	SG&A (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	582.20 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	662.10 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	1.13 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	216.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	593.21 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	347.92 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-196.26 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	247.47 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	161.89 Mn
10	Karyopharm Therapeutics	56.72 Mn	56.72 Mn	32.35 Mn	25.92 Mn

Download Data